IXICO acquires Optimal Medicine to broaden brain health expertise
IXICO has agreed a to buy the US-based digital healthcare specialist for £1.5mln .
Company
LON:IXI
IXICO is no ordinary Imaging Contract Research Organisation (iCRO). By unlocking valuable insights into drug safety and efficacy, IXICO has built a highly respected global reputation and a 20-year track record as an end-to-end iCRO. IXICO addresses the complex biomarker challenges associated with neurodegenerative conditions, expertly managing and analysing neuroimaging clinical trials in areas such as Alzheimer’s, Parkinson’s, Huntington's and other rare diseases.
263 stories · page 14 of 14
IXICO has agreed a to buy the US-based digital healthcare specialist for £1.5mln .
Investments and investor services
Below are the main news-driven share price movements at 4pm.